CABOMETYX (cabozantinib) is used in the treatment of advanced kidney and liver cancer. Created a 24 page treatment journal leveraging existing campaign imagery, for patients to track their experience on the medication, and to empower them to diligently manage their symptoms for optimized treatment experience.